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SUMMARY – The aim was to assess whether standard automated perimetry (SAP) and fre-
quency doubling technology (FDT) perimetry are able to detect the effect of diabetes mellitus (DM) 
on retinal function in DM patients in the early stage of disease and to analyze which method is more 
specific and sensitive. A randomized cross-sectional study was conducted in three different groups of 
patients to compare the capability of these two methods to examine visual field and to detect the 
change in light sensitivity. Visual function was assessed in 60 adults with normal retinal finding, 60 
adults with DM without clinically detectable retinopathy and 60 adults with DM and non-prolifera-
tive diabetic retinopathy but normal visual acuity. FDT perimetry and SAP were performed in all 
study patients. The presence and severity of diabetic retinopathy was determined by taking and evalu-
ating two 50° field color photographs per eye, macula-centered and disc-centered. The following re-
sults were obtained by analyzing parameters in the groups of diabetic patients: sensitivity and specific-
ity of SAP and FDT for medium sensitivity 86.7/33.3 (p<0.061) and 71.7/41.7 (p<0.228), respec-
tively; for medium deficit 41.7/76.7 (p<0.063) and 65/50 (p<0.362), respectively; for loss of variance/
pattern standard deviation (LV/PSD) 51.7/61.7 (p<0.536) and 61.7/51.7 (p<0.666), respectively; and 
for foveal sensitivity 81.7/36.7 (p<0.096) and 23.3/86.7 (p<0.839), respectively. Analysis of parameters 
between diabetics and control group yielded sensitivity and specificity for medium sensitivity 71.7/61.7 
(p<0.001) and 70.8/55 (p<0.002), respectively; for medium deficit 56.7/60 (p<0.058) and 77.5/43.3 
(p<0.037), respectively; for LV/PSD 58.3/58.3 (p<0.042) and 33.3/83.3 (p<0.437), respectively; and 
for foveal sensitivity 82.5/53.3 (p<0.001) and 28.3/85 (p<0.195), respectively. We concluded that nei-
ther of these methods was sensitive and specific enough to distinguish diabetics without retinopathy 
from diabetics with retinopathy. Both of these methods were highly specific and sensitive to distin-
guish diabetics from healthy subjects, but neither of these methods proved superior.
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Introduction
Diabetic retinopathy as a complication of diabetes 
mellitus (DM) is one of the most common causes of 
vision loss and visual field defects1 in developed coun-
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tries, as well as in Croatia2. Since the duration of DM 
and chronic hyperglycemia represents a risk factor for 
developing diabetic retinopathy, advancements in 
medical care and longer life span have led to an in-
crease in the prevalence of diabetic retinopathy.
Diabetic retinopathy is diagnosed and followed-up 
by funduscopy with contact or noncontact lenses (90 
diopters) with regard to the central and peripheral 
retina3. In certain cases, the following diagnostic tests 
may be supplementary in assessing the extent of dia-
betic retinopathy: fundus photography and fluorescein 
angiography, optical coherence tomography (OCT) 
and ocular ultrasound. Fluorescein angiography helps 
in assessing the risk of progression from nonprolifera-
tive to proliferative form of diabetic retinopathy4-6. 
Color fundus photography is used for detection and 
documentation of retinal changes and assesses disease 
progression or response to therapeutic procedures. 
OCT is very sensitive in detection and follow-up of 
macular edema7,8. OCT provides quantitative infor-
mation that cannot be obtained by clinical examina-
tion or fluorescein angiography, especially in the early 
stages of diabetic retinopathy. However, it does not 
provide information about microvascular retinal 
changes or leakage through the hemato-retinal barrier. 
Ocular ultrasound detects traction retinal detachment 
in severe cases of proliferative diabetic retinopathy, es-
pecially in cases of opaque optical media (cataract, vit-
reous hemorrhage)3.
Recently, static perimetry has been used in follow-
ing-up diabetic retinopathy and monitoring functional 
state of the retina. Araie et al., Werner et al. and Chau-
han et al. showed that visual field defect was the most 
significant marker of visual function9-11. Bengtsson et al. 
and Bengtsson et al. found that visual field changes may 
be used to detect progression of diabetic retinopathy12,13. 
Recent research projects are trying to find a more ap-
propriate diagnostic method to detect early changes in 
visual acuity and visual field in order to treat patients 
more efficiently in the early stages of the disease14.
Frequency-doubling technology (FDT)15 is used as 
a screening method to detect early glaucomatous16, as 
well as visual field defects caused by other diseases17. 
Frequency-doubling illusion phenomenon was origi-
nally described by Kelly18 and has been evaluated later 
by many other authors19,20. FDT is based on the stim-
uli detected by the retinal ganglion cells with long ax-
ons, i.e. magno-cells (M cells)21,22. Therefore, FDT 
should be able to detect very early defects in the visual 
field in contrast to a standard method for detecting 
visual field defects such as computerized perimetry. It 
is supposed that computerized perimetry detects visual 
field changes when already 30% of M cells are lost23,.24. 
Additional advantage of FDT over computerized pe-
rimetry is shorter duration of the test, which enables 
us to examine more patients with less discomfort in a 
short time.
The aim of this study was to determine whether the 
FDT test results in DM patients are comparable to the 
results of automated static perimetry; we also wanted 
to determine the sensitivity and specificity of FDT in 
detecting early diabetic visual field defects.
Patients and Methods
A comparative study approved by the regional in-
stitutional review board was conducted in the Depart-
ment of Ophthalmology, Osijek University Hospital 
Centre in Osijek. A total of 180 subjects were divided 
into three groups. Group 1 included diabetic patients 
without clinical signs of diabetic retinopathy; group 2 
consisted of diabetic patients with mild diabetic reti-
nopathy according to the Early Treatment Diabetic 
Retinopathy Study (ETDRS) and American Acade-
my of Ophthalmology (AAO) criteria1; group 3 con-
sisted of healthy subjects admitted for blepharoplasty 
surgery, with normal funduscopy findings, as a control 
group. All patients were older than 18 years and equal-
ly distributed according to age and sex among the 
groups. If both eyes met the inclusion criteria, only one 
eye was analyzed by random choice. Exclusion criteria 
were significant lens opacities according to the Lens 
Opacities Classification System III (LOCS3)25, glau-
coma, smokers (more than 10 cigarettes/day), alcohol-
ics (no more than three drinks per day by the National 
Institute of Alcohol Abuse and Alcoholism, NIAAA)26, 
neurologic and neuro-ophthalmologic disorders that 
may cause visual field loss.
All patients underwent complete ophthalmologic 
examination, which included medical history, visual 
acuity testing on Snellen charts, biomicroscopy, appla-
nation tonometry, funduscopy with a non-contact lens 
90 D, fundus photography 50º colors and red free in 
two fields, macula centered and optical disc centered27.
Computerized static perimetry (Octopus 123, In-
terzeag AG, Schlieren, Switzerland) and frequency-
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doubling perimetry (Frequency Doubling Perimeter, 
Welch-Allyn, Skaneateles, NY; Zeiss-Humphrey, San 
Leandro, CA) were used to examine visual fields. 
Computerized perimetry used the GX1 program with 
stimuli size Goldman III, 100 millisecond exposition 
time, 4 apostilb background illumination, maximum 
stimuli intensity of 1000 apostilbs and 4-2-1 dB 
method that determines retinal sensitivity with 1 dB 
in two phases (32 measurement spots).
The following numerical parameters were analyzed: 
medium sensitivity (MS), mean defect (MD) and loss 
of variance (LV) as a mean defect of visual field sensi-
tivity. Foveolar sensitivity was calculated out of those 
four central values as a mean value. If the reliability 
factor (RF) was less than 15%, the results were accept-
ed and considered for analysis.
The full threshold test (N-20) was used on FDT 
perimetry. It uses 17 measurement points that deter-
mine retinal sensitivity with 1 dB accuracy. The follow-
ing numerical parameters were analyzed: mean devia-
tion (MD), mean visual field sensitivity loss, and pat-
tern standard deviation (PSD) as localized visual field 
sensitivity loss that is analogous to LV in computer-
ized perimetry.
Mean sensitivity as the average sensitivity is not 
automatically calculated, so it was calculated from the 
so-called threshold diagram (a scheme of numerical 
value of sensitivity) that represents 17 stimuli thresh-
olds in different retinal locations. A central value on 
the threshold diagram was used on foveolar sensitivity 
measurement. The results were considered for analysis 
if the fixation loss or false negative error was less than 
33% and if the false positive error was less than 15%27.
Total deviation plot diagram was also analyzed and 
the criteria specific for diabetic retinopathy were de-
termined according to the results of previous studies29. 
According to this diagram, the subjects were divided 
into 9 groups, as follows: criterion 0: normal finding; 
criterion 1: one abnormal visual field in any of the 
tested areas of any intensity; criterion 2: two abnormal 
visual fields of any intensity which are not one next to 
each other except for 4; criterion 3: any two fields of 
abnormal depression one next to other except for 5; 
criterion 4: one abnormal visual field with central de-
pression or the inner ring except for 5; criterion 5: two 
abnormal visual fields in the inner ring without central 
field; criterion 6: central visual field defect; criterion 7: 
central visual field defect and minimally two fields in 
the inner ring; and criterion 8: ≥3 abnormal visual 
fields except for 7.
Such stratification of the results aimed to deter-
mine if the visual field defects had sufficient specificity 
and sensitivity to detect early diabetic retinopathy 
changes. At each visit, both perimetry tests were per-
formed. The first test was selected by random choice. 
The time interval between two perimetry tests was at 
least 30 minutes and in that time ophthalmologic ex-
amination was performed. The tests were taken by a 
perimetry technician blinded to the patient group.
Statistics
Kolmogorov-Smirnov test was used to evaluate the 
normality of distribution of numerical variables. Mann 
Whitney test was used to determine differences be-
tween two independent groups within one measure-
ment. Differences among three or more groups were 
demonstrated by Kruskal-Wallis test. χ2-test was used 
to test differences between categorical variables. Wil-
coxon test for nonparametric distribution was used to 
test differences between two dependent samples. Cor-
relation between specific parameters was tested by 
Spearman’s correlation coefficient. ROC analysis test-
ed optimal boundary values, area under ROC curve, 
specificity and sensitivity of the tested variables as a 
diagnostic method in differentiating retinopathy in 
diabetics. The p value of 0.05 was chosen to determine 
the significance of the results. The analyses were per-
formed using commercially available Statistics for 
Windows 2005 software (version 7.1, StatSoft Inc., 
Tulsa, OK, USA).
Results
In this study, we evaluated 180 subjects divided 
into three groups. Group 1 consisted of diabetic pa-
tients without clinical signs of diabetic retinopathy, 
group 2 included diabetic patients with mild diabetic 
retinopathy, and group 3 were healthy controls. There 
were 80 (44.4%) men and 100 (55.6%) women, equal-
ly distributed among groups (p=0.978). There was no 
age difference among the three groups of subjects 
(p=0.128).
Tested spots were successively labeled as VP1, 
VP2, etc. for computerized perimetry and FDTM1, 
FDTM2, etc. for FDT perimetry, starting from the 
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superior nasal part towards the inferior temporal part. 
The mean value of every single spot was obtained for 
each group of subjects and the results were analyzed to 
determine if there was a significant difference among 
different areas of visual field. Computerized perimetry 
yielded a statistically significant difference between 
diabetics with retinopathy and control group of healthy 
subjects (p<0.05 in 29 out of 32 measured points), 
whereas there was no significant difference in the loss 
of retinal sensitivity between the groups of diabetics 
with and without retinopathy (p<0.05 in 10 out of 32 
measured points).
Analysis of FDT perimetry results showed a statis-
tically significant difference between diabetics with 
retinopathy and control group of subjects (p<0.05 in 
12 out of 17 measured points), whereas there was no 
significant difference in the loss of retinal sensitivity 
between the groups of diabetics with and without reti-
nopathy (p<0.05 in 5 out of 17 measured points).
Comparative analysis of the parameters measured 
by computerized perimetry and FDT was performed. 
Medium sensitivity, mean defect and loss of variance 
were analyzed by computerized perimetry. The average 
central sensitivity of visual field, which was used for 
comparison, was calculated from the four central val-
ues of visual field.
The following parameters were analyzed in FDT: 
mean deviation, PSD, foveolar sensitivity and mean 
sensitivity of visual field. The latter parameter was cal-
culated by arithmetic mean of the sensitivity of 17 
measured spots in the visual field.
In the group of diabetics without retinopathy, there 
was a significantly higher loss of variance measured by 
computerized perimetry (4.9, interquartile range 3.1-
9.2) as opposed to 3.9 median measured with FDT. 
Diabetics with retinopathy had a significantly lower loss 
of variance measured by computerized perimetry (5.6, 
interquartile range 2.8-9.1) than the loss of variance 
measured by FDT (4.1, interquartile range 3.1-4.9).
In control group, the mean sensitivity was signifi-
cantly higher, whereas the mean central value was 
lower when measured by FDT. The mean sensitivity 
was significantly different across the three groups of 
patients on both diagnostic tests, i.e. computerized pe-
rimetry and FDT. The MS parameter was significantly 
different across the three groups of patients in both 
visual field tests, whereas MD was different when us-
ing computerized perimetry, while FDT did not detect 
significant difference among the three study groups.







Diabetics without  
vs. with retinopathy 0.066 0.232
Diabetics without retinopathy 
vs. control group 0.003 0.031
Diabetics with retinopathy  
vs. control group <0.001 0.002
All diabetics vs. control group <0.001 0.002
Mean deficiency 
Diabetics without  
vs. with retinopathy 0.069 0.365
Diabetics without retinopathy 
vs. control group 0.436 0.148
Diabetics with retinopathy  
vs. control group 0.017 0.031
All diabetics vs. control group 0.067 0.037
LV/PSD
Diabetics without  
vs. with retinopathy 0.537 0.667
Diabetics without retinopathy 
vs. control group 0.145 0.493
Diabetics with retinopathy  
vs. control group 0.055 0.519
All diabetics vs. control group 0.051 0.442
Medium central sensitivity
Diabetics without  
vs. with retinopathy 0.102 0.839
Diabetics without retinopathy 
vs. control group 0.003 0.307
Diabetics with retinopathy  
vs. control group <0.001 0.214
All diabetics vs. control group <0.001 0.190
CP = computerized perimetry; FDP = frequency doubling perim-
etry; LV = loss of variance; PSD = pattern standard deviation; 
*Mann Whitney test
Computerized perimetry detected significant MS 
difference between diabetics without and with reti-
nopathy as compared to control group of healthy sub-
jects. A significantly greater diffuse loss of visual field 
was measured in diabetics with retinopathy as com-
pared to control group (Table 1).
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Thirty-eight (21.1%) subjects had normal visual 
field, equally in all study groups. One abnormal visual 
field anywhere in the tested range was presented in 33 
(18.3%) subjects, a little less pronounced in diabetics 
without retinopathy but not statistically significant. 
Eleven (6.1%) subjects had two fields of abnormal de-
pression one next to other and only five (8.3%) control 
group subjects had one abnormal visual field in the 
center or inner ring.
Seventy-seven (42.8%) subjects had three or more 
abnormal fields except for criterion 7. The majority 
(n=30; 50%) were patients from diabetic groups and 17 
(18.3%) from control group. Results of both perimetry 
tests in diabetic groups could not identify the specific 
parameter that would identify retinopathy in the vi-
sual field of these patients.
The MS parameter differentiated diabetics from 
the control group significantly on both perimetry tests 
(p=0.002). The MD parameter tested with FDT 
helped distinguish diabetics from the control group of 
subjects. The LV parameter differentiated diabetics 
from control subjects on computerized perimetry, 
whereas PSD measured with FDT did not show sig-
nificant difference among the three groups of patients. 
The threshold central value measured with computer-
ized perimetry could distinguish diabetics from the 
control group, whereas FDT did not differentiate these 
groups of subjects (Table 2).
Discussion
Diabetic retinopathy is a significant socio-medical 
issue since it affects a large proportion of working pop-
ulation. Diagnosis and follow-up of this clinical entity 
is predominantly based on fundus examination, which 
has been standardized by the ETDRS study4, and vi-
sual acuity testing as visual function evaluation. In re-
cent time, visual field testing is introduced since it rep-
resents functional equivalent of retinal tissue damage 
and may be used to show the progression and develop-
ment of diabetic retinopathy. It has been speculated 
that it may detect signs of functional defects before 
clinically evident signs of diabetic retinopathy30. Dif-
ferent visual field tests have been evaluated and SAP 
has been shown to be more reliable and reproducible 
than standard white on white perimetry and blue on 
yellow perimetry (short wavelength perimetry)13,31. It 
is the gold standard for detecting focal retinal defects 
and glaucomatous defects. FDT visual field testing 
was developed 15 years ago and it could detect earlier 
defects in visual field in glaucoma patients28. We hy-
pothesized that it might detect early functional chang-
es in diabetic retinopathy, so we compared it to com-
puterized perimetry. We compared mean values of 
each tested spot between FDT and computerized pe-
rimetry. Computerized perimetry yielded significant 
differences among the three study groups in most of 
Table 2. Parameters of the receiver operating characteristic (ROC) curve in diabetics versus control group
Parameter AUC 95% CI Sensitivity Specificity Cut off p
Mean sensitivity
CP 0.708 0.636-0.773 71.7 61.7 ≤28.6 <0.001
FDP 0.639 0.565-0.710 70.8 55 ≤29.8 0.002
Mean deficiency
CP 0.584 0.508-0.657 56.7 60 >-0.6 0.058
FDP 0.594 0.520-0.668 77.5 43.3 ≤0.82 0.037
LV/PSD
CP 0.589 0.514-0.662 58.3 58.3 >4.6 0.042
FDP 0.535 0.460-0.610 33.3 83.3 >4.5 0.437
Medium central sensitivity
CP 0.694 0.621-0.760 82.5 53.3 ≤32.5 <0.001
FDP 0.560 0.484-0.633 28.3 85.0 ≤27 0.195
AUC = area under the curve; 95% CI = 95% confidence interval; CP = computerized perimetry; FDP = frequency doubling perimetry; LV 
= loss of variance; PSD = pattern standard deviation
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the spots tested (28 out of 32). The most significant 
difference was observed when comparing diabetics 
with diabetic retinopathy and control group (29 out of 
32), confirming the presumption that clinically detect-
able retinal changes would result in functional defects, 
which is also in accordance with literature data32,33. It 
was expected because the normal population had no 
visual field loss, whereas the patients with clinically 
detectable retinal changes had a substantial visual field 
loss31,32, which may signify underlying neuropa-
thy31,34-36, and may be the cause of  focal visual field loss 
in cases of normal funduscopy findings.
Testing by FDT perimetry showed a slight statisti-
cally significant difference across the three groups of 
subjects (8 out of 17). The most prominent differences 
were observed between diabetics with retinopathy and 
control group of patients (12 out of 17) and between 
diabetics with retinopathy and diabetics with normal 
retinal finding (1 out of 17), reflecting visual field de-
fects in specific groups of patients (patients with 
pathologic changes on funduscopy had greater visual 
field loss than healthy subjects). This was also recorded 
in computerized perimetry although the FDT test had 
fewer significantly different results than the computer 
perimetry test, which in this sense made it a less sensi-
tive method.
Jackson et al.37 demonstrated better discrimination 
of foveolar sensitivity among diabetics without reti-
nopathy, diabetics with retinopathy and control group 
of patients (p<0.0001) when testing with Matrix pe-
rimetry as compared with our study (p=0.415). Matrix 
perimetry is a new generation FDT with more testing 
spots (n=55, 5°x5°) compared to FDT test used in the 
present study (17 test spots 10°x10°). The study by 
Jackson et al. included patients with advanced stages of 
diabetic retinopathy and best corrected visual acuity 
(BCVA) 0.8 (Snellen), whereas we included mild dia-
betic retinopathy and BCVA 1.0 (Snellen), so it could 
explain the more pronounced difference and statisti-
cally significant result. The mean sensitivity loss was 
observed in diabetics with retinopathy and control 
group, which is in concordance with our results but 
they did not find significant difference between dia-
betics without retinopathy and control group. The 
mean sensitivity loss measured by Matrix perimetry 
did not significantly differ between diabetics without 
retinopathy and control group, whereas our results 
showed significant difference between these two groups 
as well (p=0.031). According to Jackson et al.37, SAP 
testing yielded no significant difference among differ-
ent groups for mean foveolar sensitivity, whereas our 
results showed significant differences (p<0.001). The 
mean sensitivity was statistically different across the 
observed groups in both studies.
In the study by Parravano et al.38, a group of diabet-
ics without retinopathy and control group of healthy 
subjects were tested with SAP and Matrix FDT pe-
rimeter. They showed significant differences in MD 
and no significant change in PSD with Matrix perim-
etry test. Our results reflected similar findings since we 
did not find significant difference in MD and PSD 
either. Using computerized perimetry, they found sig-
nificant difference in MD and PSD, whereas we re-
corded no significant difference in these two parame-
ters. According to these authors, they found a differ-
ence in MD between the two groups by using Matrix 
perimetry and SAP testing revealed significant chang-
es in both MD and PSD. Our study showed signifi-
cant difference between diabetics without retinopathy 
and healthy control group in the mean sensitivity by 
both methods and in the mean central sensitivity only 
by computerized perimetry. It may be concluded that 
computerized perimetry has advantage over FDT in 
testing diabetic visual field loss.
In the work by Realini et al.39, FDT was used in 
screening of glaucoma and they concluded that diabe-
tes might be the cause of false positive finding, where-
as Khandekar et al. in a similar study showed that dia-
betes did not influence the results of FDT test in glau-
coma patients40. We confirmed that DM might influ-
ence the results of the FDT perimetry test.
We further tried to establish if there was a pathog-
nomonic defect sample that would be characteristic of 
diabetic visual field loss, as suggested by previous re-
sults29. The only difference observed among the three 
groups was criterion 5, i.e. one abnormal central field 
or the inner ring field (χ2-test: p=0.006) and criterion 
8, i.e. three or more abnormal fields (χ2-test: p=0.022). 
Five patients in the control group and none in the 
 diabetic group of patients had visual field loss as in 
criterion 5. Diabetic patients had a more pronounced 
visual field loss and a significant difference was detect-
ed in the control group. Criterion 8 was significantly 
different in all three groups of patients but this cri-
terion encompasses many different patterns of visual 
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field loss, so it cannot represent the standardized pat-
tern.
Cross analysis of normal and pathologic visual field 
findings did not detect specific pattern of diabetic vi-
sual field loss, confirming the results reported by Par-
ravano et al.38. However, some authors showed high 
specificity and sensitivity in particular visual field 
 samples29.
The receiver operating characteristic (ROC) curve 
analyzed specificity and sensitivity of both FDT and 
computerized perimetry in the group of diabetic pa-
tients with and without retinopathy and control group. 
In both diabetic patient groups, none of the tests dif-
ferentiated the presence of retinopathy. However, both 
visual field tests differentiated diabetics from the con-
trol group of patients: SAP (p<0.001) and FDT 
(p=0.002). The MD parameter differed between dia-
betics and control group (p=0.037) when tested with 
FDT. SAP significantly differentiated loss of variance 
(p=0.042) and foveolar sensitivity (p<0.001) in diabet-
ics compared to control group. FDT and computer-
ized perimetry cannot differentiate diabetics without 
retinopathy from diabetics with retinopathy with suf-
ficient specificity and sensitivity but may differentiate 
diabetics from healthy control group of subjects. How-
ever, none of the tests showed superiority to the other.
Conclusion
Based on our data analyses, we can conclude that 
FDT may differentiate healthy subjects from diabetic 
patients equally as computerized perimetry. It does not 
discriminate well diabetics without retinopathy from 
diabetics with mild retinopathy, which, according to 
the results of our study, cannot be achieved with com-
puterized perimetry either. It is a test that is less time 
consuming than computerized perimetry, thus being 
more convenient for the patient.
We could not establish specific pattern of visual 
field loss that is pathognomonic for diabetic retinopa-
thy. FDT detected and differentiated diabetic patients 
from healthy control subjects with 70.8% sensitivity 
and 55.0% specificity for MS and 77.5% sensitivity 
and 43.3% specificity for MD. Therefore, we think that 
this test may be a useful tool in combination with oth-
er clinical methods for evaluation of diabetic visual 
field loss. Neither of the methods could discriminate 
well diabetics without retinopathy from diabetics with 
retinopathy but both tests might differentiate diabetics 
from healthy controls with sufficient sensitivity and 
specificity for MS parameter. In addition, it could not 
be confirmed that either method showed advantage 
over the other.
References
 1. Tomic M, Vrabec R, Poljicanin T, Ljubic S, Duvnjak L.  Diabetic 
macular edema: traditional and novel treatment. Acta Clin Cro-
at. 2017;56(1):124-32. doi: 10.20471/acc.2017.56.01.18
 2. Galetović D, Olujić I, Znaor L, Bućan K, Karlica D, Lesin M, 
Susac T. The role of diabetic retinopathy in blindness and poor 
sight in Split-Dalmatia County 2000-2010. Acta Clin Croat. 
2013 Dec;52(4):448-52.
 3. American Academy of Ophthalmology. Diabetic retinopathy 
Preferred Practice Pattern. 2019 Available from: www.aao.org/
ppp
 4. Early Treatment Diabetic Retinopathy Study Research Group. 
Classification of diabetic retinopathy from fluorescein angio-
grams. ETDRS report number 11. Ophthalmology. 1991;98 
(5 Suppl):807-22.
 5. Early Treatment Diabetic Retinopathy Study Research Group. 
Fluorescein angiographic risk factors for progression of dia-
betic retinopathy. ETDRS report number 13. Ophthalmology. 
1991;98(5 Suppl):834-40.
 6. Early Treatment Diabetic Retinopathy Study Research Group. 
Focal photocoagulation treatment of diabetic macular edema. 
Relationship of treatment effect to fluorescein angiographic 
and other retinal characteristics at baseline: ETDRS report no. 
19. Arch Ophthalmol. 1995;113(9):1144-55.
 7. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic 
patterns of diabetic macular edema. Am J Ophthalmol. 2006; 
142(3):405-12. doi: 10.1016/j.ajo.2006.04.023
 8. Massin P, Girach A, Erginay A, Gaudric A. Optical coherence 
tomography: a key to the future management of patients with 
diabetic macular oedema. Acta Ophthalmol Scand. 2006;84 
(4):466-74. doi: 10.1111/j.1600-0420.2006.00694.x
 9. Araie M, Yamagami J, Suziki Y. Visual field defects in normal-
tension and high-tension glaucoma. Ophthalmology. 1993;100 
(12):1808-14.
10. Werner EB, Krupin T, Adelson A, Feitl ME. Effect of patient 
experience on the results of automated perimetry in glaucoma 
suspect patients. Ophthalmology. 1990;97(1):44-8.
11. Chauhan BC, Drance SM, Douglas GR. The use of visual field 
indices in detecting changes in the visual field in glaucoma. In-
vest Ophthalmol Vis Sci. 1990;31(3):512-20.
12. Bengtsson B, Heijl A, Agardh E. Visual fields correlate better 
than visual acuity to severity of diabetic retinopathy. Diabetolo-
gia. 2005;48(12):2494-500. doi: 10.1007/s00125-005-0001-x
13. Bengtsson B, Hellgren KJ, Agardh E. Test-retest variability for 
standard automated perimetry and short-wavelength automat-
M. Bradvica et al. FDT in early detection of diabetic retinopathy
Acta Clin Croat, Vol. 59, No. 1, 2020 17
ed perimetry in diabetic patients. Acta Ophthalmol. 2008; 
86(2):170-6. doi: 10.1111/j.1600-0420.2007.01019.x
14. Landers J, Goldberg I, Graham S. A comparison of short wave-
length automated perimetry with frequency doubling perime-
try for the early detection of visual field loss in ocular hyperten-
sion. Clin Experiment Ophthalmol. 2000;28(4):248-52.
15. Cerovski B. Suvremene perimetrijske strategije i glaukom. 
Ophthalmol Croat. 2002;11(1-4):27-34. (in Croatian)
16. Takahashi G, Demirel S, Johnson CA. Predicting conversion to 
glaucoma using standard automated perimetry and frequency 
doubling technology. Graefes Arch Clin Exp Ophthalmol. 
2017;255(4):797-803. doi: 10.1007/s00417-016-3573-x
17. Tanga L, Centofanti M, Oddone F, Parravano M, Parisi V, 
 Ziccardi L, et al. Retinal functional changes measured by fre-
quency-doubling technology in patients treated with hydroxy-
chloroquine. Graefes Arch Clin Exp Ophthalmol. 2011;249 
(5):715-21. doi: 10.1007/s00417-010-1612-6
18. Kelly DH. Nonlinear visual responses to flickering sinusoidal 
gratings. J Opt Soc Am. 1981;71(9):1051-5.
19. Richards W, Felton TB. Spatial frequency doubling: retinal or 
central. Vision Res. 1974;13:1229-37.
20. Tyler CW. Observations on spatial-frequency doubling. Per-
ception. 1974;3(1):81-6.
21. Johnson CA, Demirel S. The role of spatial and temporal fac-
tors in frequency-doubling perimetry. In: Wall MH, editor. In-
ternational Perimetric Society Meeting. Amsterdam/New 
York: Kugler; 1996. p. 13-9.
22. Burnstein Y, Ellish NJ, Magbalon M, Higginbotham EJ. Com-
parison of frequency doubling perimetry with Humphrey vi-
sual field analysis in a glaucoma practice. Am J Ophthalmol. 
2000;129(3):328-33. doi: S0002939499003645
23. Pederson JE, Anderson DR. The mode of progressive disc cup-
ping in ocular hypertension and glaucoma. Arch Ophthalmol. 
1980;98(3):490-5.
24. Quigley HA, Addicks EM, Green WR. Optic nerve damage in 
human glaucoma. III. Quantitative correlation of nerve fiber 
loss and visual field defect in glaucoma, ischemic neuropathy, 
papilledema, and toxic neuropathy. Arch Ophthalmol. 1982; 
100(1):135-46.
25. Thylefors B, Chylack LT Jr, Konyama K, Sasaki K, Sperduto R, 
Taylor HR, et al. A simplified cataract grading system. Oph-
thalmic Epidemiol. 2002;9(2):83-95.
26. de Carvalho JF, Danda D, Dantas H, Arraes TA, Cavalcanti E. 
[Blue-on-yellow perimetry in tobacco and alcohol consumers]. 
Arq Bras Oftalmol. 2006;69(5):675-8. doi: S0004-27492006 
000500010 (in Portuguese)
27. Saari JM, Summanen P, Kivela T, Saari KM. Sensitivity and 
specificity of digital retinal images in grading diabetic retinopa-
thy. Acta Ophthalmol Scand. 2004;82(2):126-30. doi: 10.1111 
/j.1600-0420.2004.00240.x
28. Liu S, Lam S, Weinreb RN, Ye C, Cheung CY, Lai G, et al. 
Comparison of standard automated perimetry, frequency-dou-
bling technology perimetry, and short-wavelength automated 
perimetry for detection of glaucoma. Invest Ophthalmol Vis 
Sci. 2011;52(10):7325-31. doi: 10.1167/iovs.11-7795
29. Parikh R, Naik M, Mathai A, Kuriakose T, Muliyil J, Thomas 
R. Role of frequency doubling technology perimetry in screen-
ing of diabetic retinopathy. Indian J Ophthalmol. 2006;54 
(1):17-22.
30. Pahor D. [Reduction of retinal light sensitivity in diabetic pa-
tients]. Klin Monbl Augenheilkd. 2003;220(12):868-72. doi: 
10.1055/s-2003-812556 (in German)
31. Jackson GR, Barber AJ. Visual dysfunction associated with di-
abetic retinopathy. Curr Diab Rep. 2010;10(5):380-4. doi: 
10.1007/s11892-010-0132-4
32. Pahor D. Automated static perimetry as a screening method for 
evaluation of retinal perfusion in diabetic retinopathy. Int Oph-
thalmol. 1997;21(6):305-9.
33. Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of 
diabetic retinopathy: clues towards understanding pathoge-
nesis? Eye (Lond). 2009;23(7):1496-508. doi: 10.1038/eye. 
2009.108
34. Bek T. Localized retinal morphology and differential light sen-
sitivity in diabetic retinopathy. Methodology and clinical re-
sults. Acta Ophthalmol Suppl. 1992;207:1-36.
35. Barber AJ, Gardner TW, Abcouwer SF. The significance of vas-
cular and neural apoptosis to the pathology of diabetic reti-
nopathy. Invest Ophthalmol Vis Sci. 2011;52(2):1156-63. doi: 
10.1167/iovs.10-6293
36. Gardner TW, Abcouwer SF, Barber AJ, Jackson GR. An inte-
grated approach to diabetic retinopathy research. Arch Oph-
thalmol. 2011;129(2):230-5. doi: 10.1001/archophthalmol. 
2010.362
37. Jackson GR, Scott IU, Quillen DA, Walter LE, Gardner TW. 
Inner retinal visual dysfunction is a sensitive marker of non-
proliferative diabetic retinopathy. Br J Ophthalmol. 2012;96 
(5):699-703. doi: 10.1136/bjophthalmol-2011-300467
38. Parravano M, Oddone F, Mineo D, Centofanti M, Borboni P, 
Lauro R, et al. The role of Humphrey Matrix testing in the 
early diagnosis of retinopathy in type 1 diabetes. Br J Ophthal-
mol. 2008;92(12):1656-60. doi: 10.1136/bjo.2008.143057
39. Realini T, Lai MQ, Barber L. Impact of diabetes on glaucoma 
screening using frequency-doubling perimetry. Ophthalmolo-
gy. 2004;111(11):2133-6. doi: 10.1016/j.ophtha.2004.05.024
40. Khandekar R, Zutshi R, Ali M, Raisi AA, Dass H. Influence of 
diabetes on the validity glaucoma screening by frequency dou-
bling perimetry: a hospital-based study in Oman. Diabetes 
Technol Ther. 2008;10(4):278-82. doi: 10.1089/dia.2007.0272
M. Bradvica et al. FDT in early detection of diabetic retinopathy
18 Acta Clin Croat, Vol. 59, No. 1, 2020
Sažetak
ULOGA FDT PERIMETRIJE U RANOM OTKRIVANJU DIJABETIČKE RETINOPATIJE
M. Bradvica, D. Biuk, I. Štenc Bradvica, M. Vinković, B. Cerovski i I. Barać
Cilj rada bio je utvrditi mogu li standardna automatizirana perimetrija (SAP) i perimetrija udvostručene frekvencije 
(frequency doubling technology, FDT) otkriti učinke dijabetesa na funkciju retine u osoba s dijabetesom u ranoj fazi bolesti i 
ocijeniti koja je metoda bolja, jer se dosadašnji radovi spore oko činjenice može li FDT otkriti funkcionalne promjene u 
bolesnika s dijabetesom prije SAP-a. Svim ispitanicima koji su zadovoljili uključne kriterije testirano je vidno polje pomoću 
SAP-a i FDT perimetrije. Dobiveni parametri statistički su obrađeni i doneseni su zaključci o valjanosti otkrivanja oštećenja 
vidnog polja upotrebom svakog od testova. Vidna funkcija istražena je u tri skupine od po 60 ispitanika. Prvu skupinu činili 
su zdravi ispitanici, drugu bolesnici s dijabetesom bez klinički vidljive dijabetičke retinopatije, a treću skupinu bolesnici s 
dijabetesom i klinički vidljivom početnom neproliferacijskom dijabetičkom retinopatijom. Postojanje dijabetičke retinopa tije 
utvrđeno je analizom dviju fotografija očne pozadine širine 50°, jedna s centrom u makuli i druga s centrom na papili vidno-
ga živca. Analizirajući parametre među skupinama dijabetičara nađena je osjetljivost i specifičnost SAP-a i FDT-a za srednju 
osjetljivost (SO) 86,7/33,3 (p<0,061) i 71,7/41,7 (p<0,228), za srednji deficit (SD) 41,7/76,7 (p<0,063) i 65/50 (p<0,362), za 
loss of variance/pattern standard deviation (LV/PSD) 51,7/61,7 (p<0,536) i 61,7/51,7 (p<0,666) te za foveolarnu osjetljivost 
81,7/36,7 (p<0,096) i 23,3/86,7 (p<0,839). Analizirajući parametre između skupina dijabetičara i kontrolne skupine zdravih 
ispitanika nađeni su sljedeći podatci: osjetljivost i specifičnost SAP-a i FDT-a za SO 71,7/61,7 (p<0,001) i 70,8/55 (p<0,002), 
za SD 56,7/60 (p<0,058) i 77,5/43,3 (p<0,037), za LV/PSD 58,3/58,3 (p<0,042) i 33,3/83,3 (p<0,437) te za foveolarnu 
osjetljivost 82,5/53,3 (p<0,001) i 28,3/85 (p<0,195). Zaključak je bio da nijedna od navedenih metoda ne može primjereno 
razlučiti dijabetičare bez retinopatije od dijabetičara s retinopatijom, ali obje metode s razumnom osjetljivošću i specifičnošću 
razlikuju dijabetičare od zdravih ispitanika prema parametru SO. Također nije bilo moguće potvrditi da je jedna metoda 
značajno bolja od druge.
Ključne riječi: Dijabetes melitus; Dijabetična retinopatija; Vidno polje, testovi; Fotofobija; Vidna oštrina
